Drug: Matching Placebo: chronic pain clinical trials

Registry records that list "Drug: Matching Placebo" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

2 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Provinces
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain NCT00973024	Terminated	Phase 2	British Columbia, Newfoundland and Labrador, Ontario, Quebec	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2009-09
A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated NCT03765658	Completed	Phase 1	Ontario	Grünenthal GmbH	2006-01-20

4 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants NCT04265781	Completed	Phase 1	Japan	Bayer	2020-02-15
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves NCT01939366	Completed	Phase 2	Austria, Denmark, France, Germany and 4 more	Tris Pharma, Inc.	2013-09-27
Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. NCT01725087	Completed	Phase 2	Austria, Belgium, Denmark, Finland and 7 more	Tris Pharma, Inc.	2012-11
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy NCT01347671	Completed	Phase 2	Bulgaria, Germany, Romania	Tris Pharma, Inc.	2011-05

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.